特发性血小板减少性紫癜：不确定性中的指南
Idiopathic thrombocytopenic purpura: guidance amid uncertainty.
作者信息
Lichtin A
机构信息
Department of Hematology and Medical Oncology, Cleveland Clinic, USA.
出版信息
Cleve Clin J Med. 1998 Nov-Dec;65(10):510-4. doi: 10.3949/ccjm.65.10.510.
PMID:9830783
Abstract
Clinical guidelines for treating ITP are based on the consensus of an expert panel, as randomized trials are lacking. Newer genetically engineered treatments hold promise but await definitive study.
摘要
由于缺乏随机试验，治疗免疫性血小板减少症（ITP）的临床指南是基于专家小组的共识制定的。新型基因工程疗法有望取得成效，但仍有待进行确定性研究。
Zotero 插件